|Bid price||1,356.00||Open price||1,319.00|
|Ask price||1,360.00||Prev close||1,323.00|
Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.
Register now for FREE Dechra Pharmaceuticals share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB0009633180|
|Activites||Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products.||Index||FTSE 250|
|Latest Share Price (p)||1,358.00||Net Gearing (%)||43.69|
|Market Capitalisation (£m)||1,231.75||Gross Gearing (%)||50.67|
|Shares in issue (m)||92.75||Debt Ratio||44.06|
|P/E Ratio||94.86||Debt-to-Equity Ratio||0.77|
|Total dividends per share (p)||18.46||Assets / Equity Ratio||2.03|
|Dividend Yield (%)||1.39||Price to book value||4.45|
|Dividend cover (x)||1.25||ROCE (%)||2.94|
|Earning per share (p)||14.00||EPS Growth (%)||-36.77|
|52 week high / low||1,438.50 / 811.00||DPS Growth (%)||8.97|
|Dec.Date||Type||Director||Pos||No. of Shares|
/* */ RNS Number : 3845K Dechra Pharmaceuticals PLC 21 September 2016 Wednesday, 21 September 2016 Dechra ® Pharmaceuticals PLC (the Company) Annual Financial Report The Company announced...
/* */ RNS Number : 2354K Dechra Pharmaceuticals PLC 19 September 2016 The announcement below replaces an announcement released in error on 15 September 2016 under RNS number 9802J. That announcement should have been released on 19 September 2016 in relation to...
Dechra has agreed terms to acquire the business and assets of Apex Laboratories Pty, a privately owned veterinary pharmaceutical company which manufactures, markets and sells branded non-proprietary prescription and other related companion animal products in Australia and New Zealand. The...
Register now for FREE Dechra Pharmaceuticals company news
A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...
Register now for FREE Dechra Pharmaceuticals share price discussions